Chronic Kidney Disease News

University of Washington researchers are conducting a survey among kidney care professionals on how they present palliative care options to patients who are facing kidney failure.

The cholesterol benefits of bempedoic acid plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported.

Kidney transplant recipients with HIV who receive kidneys from deceased donors with HIV show positive overall and allograft survival, according to a presentation at the American Transplant Congress.

Among kidney transplant recipients with uncontrolled gout, pegloticase showed sustained decreased serum urate levels, according to findings presented at the American Transplant Congress.

NEW ORLEANS — Providers should use evidence-based recommendations to educate people with diabetes on misconceptions surrounding net carbohydrates, artificial sweeteners and very low-carbohydrate diets, according to a speaker.

NEW ORLEANS — Tirzepatide, a novel glucose-lowering therapy, reduced urinary albumin secretion and slowed kidney function decline for adults with type 2 diabetes and high cardiovascular risk, according to data from the SURPASS-4 trial.

The Kidney Health Initiative, a public-private partnership between the American Society of Nephrology, the FDA and more than 100 organizations, has launched the End-Stage Kidney Disease Data Standards Project.

A second kidney transplant correlates with better survival compared with dialysis treatment, according to data published in the American Journal of Transplantation.

The American Diabetes Association announced updates to its 2022 Standards of Medical Care in Diabetes to reflect new data on cardiovascular outcomes with diabetes and kidney disease and use of SGLT2 inhibitors.

Fewer than one in 10 adults with type 2 diabetes in the U.S. use SGLT2 inhibitors or GLP-1 receptor agonists, and only SGLT2 inhibitors have seen an increase in use over the last decade, according to study findings.